
Supporting Appropriate Proton Pump Inhibitor Prescribing in Albertan Primary Care
Gastroenterology (Digestive Health)
2018-04-01 – 2019-03-15
Proton Pump Inhibitors are a group of drugs used to reduce stomach acid production. In Alberta, over 450,000 people were dispensed proton pump inhibitor (PPI) medications from community pharmacies in 2016/17. Over half of patients taking a PPI in Alberta may not have a proper indication, representing avoidable medication burden, health risks and system costs. Chronic PPI use has been associated with adverse health events that should be minimized if the use of PPI is no longer indicated. PPI use should be continuously evaluated and de-prescribed whenever possible. In many cases, there is a valid indication for starting PPI therapy, but it is very often
continued long past the time where its use is required.
We engaged with physicians and patients to understand and explore how to support appropriate PPI prescribing in primary care. We found that patients had difficulty describing their symptoms and often misused the term acid reflux. There was a gap in healthcare provider knowledge surrounding what was classified as long-term PPI therapy and the adverse health impacts associated with PPIs. We created a best practices document on long term PPI therapy for primary care physicians. We also used geographic heat maps to determine areas of higher use in order to tailor and target interventions. In addition, we created prescription tools and patient education materials to help patients better describe their symptoms and speak with their family physician about their use of PPIs.